Olema Pharmaceuticals Inc Share Price

NASDAQ: OLMA

Small Cap

$7.75

-0.14

(-1.77%)

as on September 18, 2025 at 1:29 am IST

$₹

Olema Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$7.66
Day's Price Range
$8.04
$7.75
1.16%
Downside
3.74%
Upside
52 Week's Low
52 Week's High
$2.86
52-Week Price Range
$13.93
$7.75
63.10%
Downside
79.74%
Upside

Olema Pharmaceuticals Inc share price movements today

Previous Close: $7.89
Open: $7.89
Volume: 894.7K
Day's Low - High: $7.66 - $8.04
52 Week Low - High: $2.86 - $13.93

Olema Pharmaceuticals Inc Historical Returns

1 Month Return: + 43.19 %
3 Month Return: + 96.76 %
1 Year Return: -35.7 %
3 Year Return: + 109.28 %
5 Year Return: 0 %

Olema Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Olema Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$549.1M

EPS (TTM)

-1.806

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-151.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

489545500.00%

Olema Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Olema Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Olema Pharmaceuticals Inc	BUY	$549.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Olema Pharmaceuticals Inc Stock including INR - Dollar returns

The Olema Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Olema Pharmaceuticals Inc investment value today

Current value as on today

₹67,760

Returns

₹32,240

(-32.24%)

Returns from Olema Pharmaceuticals Inc Stock

₹36,838 (-36.84%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Olema Pharmaceuticals Inc Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Olema Pharmaceuticals Inc. Average target price of $25

Olema Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Olema Pharmaceuticals Inc.

What analysts predicted

69%UPSIDE

Target Price

$25

Current Price

$7.75

Analyzed by

16 Analysts

Target

$25.00

Olema Pharmaceuticals Inc target price $25, a slight upside of 69% compared to current price of $7.75. According to 16 analysts rating.

Olema Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Olema Pharmaceuticals Inc Stock has increased by 531% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:531% versus previous 30 day period

Olema Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	-	0	-	-
Gross Profit	0	0	0	1	0	0	0	0	0	-
Operating Income	-29	-21	-23	-30	-34	-33	-37	-36	-34	-47
EBITDA	-29	-21	-23	-30	-34	-33	-37	-36	-34	-47
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-28	-20	-21	-26	-30	-30	-34	-33	-30	-43
Income Tax Expense	-1	-1	-1	4	-3	-	-	3	-	-
Net Income	-26	-20	-21	-26	-30	-30	-34	-33	-30	-43
Net Profit Margin	0.00%	0.00%	0.00%	-1421.02%	0.00%	0.00%	0.00%	-9221.70%	0.00%	0.00%

Olema Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	-1	-1	0	0
Operating Income	-2	-4	-21	-71	-106	-104	-142
EBITDA	-2	-4	-21	-69	-106	-104	-129
Interest Expense	0	-	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-2	-4	-22	-71	-104	-96	-129
Income Tax Expense	0	0	0	0	-2	-	0
Net Income	-2	-4	-22	-70	-102	-96	-129
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Olema Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-20	-21	-26	-30	-30	-34	-33	-30	-43
Operating Cash Flow	-22	-22	-18	-23	-27	-27	-26	-43	-29
Investing Cash Flow	14	-25	-30	-20	-4	45	-114	-45	34
Financing Cash Flow	2	130	0	8	15	0	244	0	-2
Change in Cash	-5	82	-48	-34	-16	18	103	-88	1

Olema Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-22	-71	-104	-96	-129
Operating Cash Flow	-3	-19	-50	-82	-83	-104
Investing Cash Flow	0	0	-275	91	-4	-93
Financing Cash Flow	358	358	1	0	133	268
Change in Cash	-3	338	-324	9	44	70

Global Institutional Holdings in Olema Pharmaceuticals Inc

Funds	Holdings
Bain Capital Life Sciences Investors, LLC	10%
Paradigm Biocapital Advisors LP	9.85%
Bvf Inc	7.74%
BlackRock Inc	5.59%
Deep Track Capital, LP	5.03%

See all

Insights on Olema Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, OLMA stock has moved up by 37.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 107.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 7.2%

About Olema Pharmaceuticals Inc

olema oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. our lead program, op-1250, a potential best-in-class complete estrogen receptor antagonist (ceran), is in development to treat estrogen receptor-positive (er+), human epidermal growth factor receptor 2-negative (her2-) breast cancer. olema recently initiated a phase 1/2 dose-escalation and expansion clinical trial of op-1250. we are supported in our mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies. for more information about the company please visit www.olema.com.

Organisation	Olema Pharmaceuticals Inc
Headquarters	780 Brannan Street, San Francisco, CA, United States, 94103
Industry	Health Technology
CEO	Dr. Sean P. Bohen M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Olema Pharmaceuticals Inc

Name	Title
Dr. Sean P. Bohen M.D., Ph.D.	President, CEO & Director
Mr. Shane William Charles Kovacs M.B.A.	Chief Operating & Financial Officer
Dr. Kamesh Kuchimanchi Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance
Ms. Julie Dexter	Senior VP & Head of People
Dr. David C. Myles Ph.D.	Chief Discovery & Non-Clinical Development Officer
Mr. Richard Hernandez	Senior Vice President of Clinical Development Operations
Dr. Mark Shilkrut M.D., Ph.D.	Senior Vice President of Clinical Development
Dr. Naseem Zojwalla M.D.	Chief Medical Officer
Ms. Shawnte M. Mitchell J.D.	Chief Legal Officer & Corporate Secretary
Ms. Courtney O'Konek	Vice President of Corporate Communications

FAQs

What is Olema Pharmaceuticals Inc share price today?

Olema Pharmaceuticals Inc share price today is $7.75 as on September 18, 2025 at 1:29 am IST at the close of the market. Olema Pharmaceuticals Inc share today touched a day high of $8.04 and a low of $7.66.

What is the 52 week high and 52 week low for Olema Pharmaceuticals Inc share?

Olema Pharmaceuticals Inc share touched a 52 week high of $13.93 on September 23, 2024 and a 52 week low of $2.86 on April 7, 2025. Olema Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $7.75,which is 44.36% down from its 52 week high and 170.98% up from its 52 week low.

What is Olema Pharmaceuticals Inc's market capitalisation today?

Olema Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Olema Pharmaceuticals Inc Stock (OLMA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Olema Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Olema Pharmaceuticals Inc Shares that will get you 0.1935 shares as per Olema Pharmaceuticals Inc share price of $7.75 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Olema Pharmaceuticals Inc Stock (OLMA) from India?

Indian investors can start investing in Olema Pharmaceuticals Inc (OLMA) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 6:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Olema Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 6:37 am IST). Based on Olema Pharmaceuticals Inc share’s latest price of $7.75 as on September 18, 2025 at 1:29 am IST, you will get 1.2903 shares of Olema Pharmaceuticals Inc. Learn more about fractional shares .